Static snapshot, generated 13 November 2026. Not updated, no live prices.

JPMorgan Chase (JPM) research report

JPM at $344.58 [E0919] trades 15% above our blended fair value of $292.72 [E0368, E0417], on 2.6x book [E0468] and 14.4x trailing earnings [E0470], while the market is priced for a benign outcome in which asset-sensitive net interest income holds [E0002, E1661]. Kalshi odds of a December hike of about 96% [E0796] favour NII, but 37.5% recession odds [E0821] and a thin credit evidence base mean the January 14, 2027 print [E0300] decides whether the premium to our model is earned.

This is a stored Pegasus Alpha report, shown as it was written on 13 November 2026. Markers like [E0078] point to numbered items in that report's evidence pack; every claim is cited or marked as our inference. Prices and figures are as of the report date.

Investment thesis

JPMorgan Chase is the largest US universal bank, with $4.4 trillion of assets and $362.4 billion of equity at year-end 2025 [E0097]. Revenue was $182.4 billion in 2025, split across the Commercial and Investment Bank ($78.5bn), Consumer and Community Banking ($76.0bn) and Asset and Wealth Management ($24.1bn) [E0162, E0130, E0137, E0144].

What is happening now: the rate path is the story. The 10-K says higher rates lift net interest income [E1573], and management said on the October 2026 call that JPM is asset sensitive, probably more than the earnings-at-risk disclosure shows, because consumer deposit betas are lower than modeled [E1661]. Kalshi odds of a December hike are about 96% (tier 5, market-implied) [E0796]. Fed funds are 3.88% and the 10Y yield 4.98% [E0561, E0616].

What the price seems to assume: at $344.58 the stock trades at 2.6x book, 14.4x trailing and 13.5x forward earnings [E0919, E0468, E0470, E0469]. Our justified-P/B model gives $258.12 and trading comps $274.58, so the blended fair value of $292.72 is 15% below the price [E0413, E0407, E0368, E0417]. The premium implies the market capitalises the higher TTM ROE of 18.0% [E0494] rather than the 16.1% annual figure used in our model [E1286].

Our read (inference): the market prices a benign pairing of rate-driven NII and quiet credit. The two live threats are recession, which the Scenario Lab weights at 37.5% with a regime mean return of -16.6% [E0986, E1057], and deposit betas catching up. The pack holds no deposit, allowance or NII guidance series, so we cannot test either directly.

Biggest risk to this read: a hawkish path that raises NII faster than credit costs and funding costs rise. The January 14, 2027 print [E0300] is the first hard test.

Key debates and what is priced in

1. Do low deposit betas persist through a hiking cycle? Market's take: JPM is asset sensitive and NII holds [E0002]. Our read: management says betas are lower than modeled [E1661], and that is the brief's first must-be-true condition [E0003]. The pack has no deposit cost series, so it is unverified. Settles on the January 14, 2027 print and NII guidance [E0300].

2. Is the price paying for TTM ROE or annual ROE? Market's take: the stock trades above model value, consistent with 18.0% TTM ROE [E0494]. Our read: the justified-P/B model uses 16.1% ROE and 9.7% cost of equity [E1286, E1282]; even its bull case of $316.90 sits below the $344.58 price [E0410, E0919]. Settles when four-quarter ROE confirms a durable 17%-plus level.

3. Is the hawkish rate path a tailwind or a recession trigger? Market's take: Kalshi implies about 96% odds of a December hike and 58% for January [E0796, E0801]. Our read: the Scenario Lab weights hawkish at 59.3% and recession at 37.5% [E0985, E0986]; Q3 RWA already rose about $52 billion on energy prices and volatility [E1683]. Settles on December 9 and January FOMC outcomes and HY spread moves from today's 3.2% [E0793, E0572].

4. Do regulation and politics bite capital return? Market's take: regulation stays manageable [E0002]. Our read: the debit interchange cap is the one concrete revenue threat and is tied up in litigation [E0100, E0101]; the Senate Epstein-related probe is a single tier-4 headline and unconfirmed [E1141]. Settles on the Fed's interchange decision and any confirmed docket.

Consensus: 23 analysts, mean recommendation 2.04, with targets of $312 to $425 and a mean of $373.48, which is 8.6% above the price [E0446, E0477, E0487, E0486, E0488, E0495]. We report these as consensus estimates without using them as a valuation conclusion.

Priced in: the stock trades at 13.5x forward earnings and 2.6x book [E0469, E0468]. Our justified P/B inputs (ROE 16.1%, cost of equity 9.7%, growth 2.5%) imply $258.12 [E1286, E1282, E1290, E0413]. Closing the gap to the $344.58 price needs either higher sustained ROE (TTM is 18.0% [E0494]) or a lower discount rate.

A reverse DCF is not applicable: the DCF engine is disabled because banks require a book-value model rather than a cash-flow DCF [E0992]. The justified-P/B comparison is our substitute. Comparison of implied growth and margins with history cannot be completed with the evidence provided.

Valuation

Model output, not a target. The blended fair value is $292.72, weighting justified P/B 40%, trading comps 35% and analyst consensus 25% [E0368, E0414, E0408, E0402]. The price of $344.58 is 15.1% above it [E0416, E0417].

Justified P/B: base $258.12, bear $204.01, bull $316.90, using book value per share of $136.48, ROE 16.1%, cost of equity 9.7% (beta 1.05, risk-free 4.98%, ERP 4.5%) and terminal growth 2.5% [E0413, E0412, E0410, E1284, E1286, E1282, E1280, E0976, E1283, E1290].

Multiples: P/E 14.4x trailing and 13.5x forward, P/B 2.6x, PEG 1.46 [E0470, E0469, E0468, E0471]. Trading comps give $274.58 with a range of $260.85 to $288.31 [E0407, E0406, E0404].

Distribution: the 12-month scenario SIMULATED Monte Carlo gives a median of $333.01 with a P10 to P90 range of $210.24 to $486.83 [E0396, E0395, E0392]. Sum-of-parts is not run; the pack provides no segment profit data. The analog engine is flagged report-context only with survivorship-bias caveats, so historical analog returns are not used [E1008, E1011].

Three cases, with the model range from the Scenario Lab. These are model ranges, not targets. Likelihood buckets: bull 27%, base 43%, bear 30% (our judgement from the evidence weights).

CaseWhat has to be trueEarly signsModel range (stock return)Likelihood
BullRates stay higher, deposit betas stay low, credit holds [E1573, E1661]NII guidance reaffirmed on 2027-01-14 [E0300]Soft-landing regime mean +18.0% [E1066]; hawkish P90 +47.9% [E1051]27%
BaseNII roughly holds; capital pressure and credit cost offsetHY spread near 3.2%; RWA growth [E0572, E1683]Hawkish median +5.4%, mean +8.9% [E1050, E1048]43%
BearRates fall or recession; betas catch up; credit costs rise [E0008, E0003]HY spread widening; deposit pricing [E1595]Recession mean -16.6%, P10 -49.4% [E1057, E1058]30%

Catalysts and timeline

The next earnings release is 2027-01-14 and is confirmed by Yahoo Finance [EARN-1, E0300]. Fed decision dates come from the Kalshi markets [E0793, E0798, E0803, E0808].

DateEventWhy it mattersWhat to watch
2026-12-09FOMC decisionKalshi implies about 96% odds of a hike [E0795, E0796]Hike vs hold; deposit pricing response
2027-01-14Q4 2026 earnings (confirmed) [EARN-1]First test of NII guidance and credit costs [E0001]NII guidance, deposit betas, credit costs, RWA
2027-01-27FOMC decisionHike odds 58.4% [E0801]Rate path and curve shape
2027-03-17FOMC decisionHike odds 60.3% [E0806]Rate path, recession signals
2027-04-28FOMC decisionHike odds 23.1%, cut odds 14.6% [E0811, E0810]Pivot signals

Risks

Risks by folder. See the structured block for the full list.

Company overview and business model

JPMorganChase describes itself as a leader in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing and asset management, serving millions of customers predominantly in the US [E0098, E0099]. It had 318,512 employees at December 31, 2025 [E0084] and is headquartered at 270 Park Avenue, New York [E0094].

How it makes money: the durable earner is net interest income from lending and deposits, supplemented by fees and markets revenue. Revenue was $182.4 billion in 2025, up from $177.6 billion in 2024 and $158.1 billion in 2023 [E0162, E0163, E0164].

Mix by segment (2025): Commercial and Investment Bank $78.5bn (43.0%), Consumer and Community Banking $76.0bn (41.7%), Asset and Wealth Management $24.1bn (13.2%) [E0130, E0127, E0137, E0134, E0144, E0141]. The segment shares sum to 97.9%, so a corporate and other item accounts for the remainder [E0147].

Geography: North America generated $139.7bn (76.6%) and international $42.8bn (23.4%) of 2025 revenue, with EMEA the largest non-US region at $24.5bn [E0052, E0049, E0059, E0056, E0066]. The geographic shares sum to 123.4%, so the geography rows overlap and should be read as indicative [E0083].

Concentration: the disclosed concentration data covers collateral, not customers. 95% of the commercial credit exposure in that disclosure is secured by highly liquid collateral at year-end 2025, versus 94% a year earlier [E0022, E0032]. Item 1 names no key suppliers [E0041].

Industry and competitive position

JPM competes against banks, brokerages, investment banks, hedge funds, private equity firms, insurers, asset managers, card companies and other financial firms, and competes on product quality, execution, innovation, reputation and price [E0016, E0017]. Competition varies by client type, industry and geography [E0018].

Peer set: the filing-based peer screen returned only two names that mention JPM in their own 10-Ks (Marriott and Paymentus), which are not true bank comparables [E0644, E0652, E0641]. The Yahoo classification is Banks - Diversified within Financial Services [E0639, E0640]. The trading-comps leg of fair value gives $274.58, with a $260.85 to $288.31 range, implying peers trade at lower multiples than JPM [E0407, E0406, E0404].

Moat (inference, sliding scale): scale in a regulated industry, $4.4 trillion of assets and a broad product set suggest a wide moat on funding and distribution [E0097], but the pack contains no market share, deposit share or cost-to-income data to measure it. Regulatory change, notably the debit interchange cap proposal, is the visible structural threat to one revenue line [E0100]. Industry size, growth and share trends are not available in the evidence pack.

Management, governance, government and insiders

Key people: Jamie Dimon is Chairman and CEO and Jeremy Barnum is Chief Financial Officer, both named on the October 2026 earnings call [E1617]. Robin Leopold (Head of Human Resources) and Stacey Friedman (General Counsel) are insiders who sold stock under pre-planned schedules in the last six months [E0183, E0199, GOV-14, GOV-16].

Links and exposure: reported legal matters name the CEO personally in a suit alleging the bank closed accounts for political reasons; it is news-only and unverified [LEG-3, E0522]. A Senate Epstein-related probe reported in a single headline is tier 4 and unconfirmed [E1141]. We frame these as unverified risks, not findings against any person.

Succession: a Polymarket market on the next CEO exists but has only $125.62 of volume, so it carries no signal [E0789, E0792]. Insider ownership is 0.4% and institutions hold 75.4% [E0459, E0460].

Not in the pack: pay against performance, board independence, related-party deals and share class structure.

SEC Form 4: 19 insider trades over two years with 0 purchases and 19 sales, all pre-planned under 10b5-1 [GOV-6]. In the last 180 days, four sales totalled $5.24 million: Robin Leopold (Head of Human Resources) sold 2,500 shares on each of 2026-08-11 and 2026-09-10, and Stacey Friedman (General Counsel) sold about 5,467 shares on each of 2026-05-20 and 2026-06-22 [E0178, GOV-14, GOV-15, GOV-16, GOV-17]. Pre-planned sales carry little signal.

Lobbying: 10 filings in three years totalling $430K; PHRONESISDC, LLC lobbies for JPM at about $50K a quarter on banking issues, including the Senate, House and White House [GOV-2, GOV-9, GOV-10, GOV-11].

Checked with nothing found: Congress trades, federal contracts, FDA decisions and clinical trials [GOV-1, GOV-3, GOV-4, GOV-5]. Regulators and filings show three records naming the company, all Schedule 13G filings [GOV-7, GOV-19].

Financial analysis and model summary

Growth: revenue was $182.4bn in 2025 (+2.75% year on year) with a 3-year CAGR of 12.3% [E0478, E0480, E0479]. Net income was $57.0bn, down 2.4% on the year, while TTM earnings growth is reported at 9.9% and TTM revenue growth at 10.2%; the FY and TTM series conflict and the pack does not reconcile them [E0463, E0464, E0489, E0493].

Margins and returns: operating margin 44.8%, net margin 31.3%, ROE 16.1% (TTM 18.0%), ROA 1.29% [E0466, E0465, E0482, E0494, E0481].

Cash conversion: reported operating cash flow and FCF are -$147.8bn for 2025 (FCF yield -16.2%) [E0442, E0457]. For a bank this is a balance-sheet artefact of trading and lending flows, not a distress signal; it drives the Piotroski score of 3 of 7 and the Altman test is not meaningful for banks [E0894, E0891]. We do not read cash flow vs net income as an earnings-quality signal here.

Balance sheet: total assets $4.42 trillion, equity $362.4 billion, net debt -$278.6bn (net cash), debt/equity 0.18 [E0436, E0097, E0462, E0448]. The pack contains no debt maturity ladder, CET1 ratio or allowance series, so refinancing and capital adequacy cannot be assessed.

Capital allocation: dividend yield 1.9% with a payout ratio of 25.8%, and the share count fell 3.4% year on year [E0449, E0467, E0484]. ROIC against cost of capital: the 16.1% ROE compares with a 9.7% cost of equity [E0482, E1282].

Only headline figures are in the pack; full standardised statements for five years plus TTM are not. Figures below are cross-checked between SEC and Yahoo and agree within 0.33% [E0420, E0426, E0432, E0438].

MetricValueAs of
Revenue$182.4bn [E0478]2025-12-31
Net income$57.0bn [E0463]2025-12-31
Operating margin44.8% [E0466]TTM
ROE (FY / TTM)16.1% / 18.0% [E0482, E0494]2025 / TTM
Total assets$4.42tn [E0436]2025-12-31
Net debt-$278.6bn [E0462]latest
Piotroski3 of 7 [E0894]latest
LineSEC valueYahoo value
Revenue$182.45bn [E0424]$181.85bn [E0425]
Net income$57.05bn [E0430]$57.05bn [E0431]
Total assets$4.42tn [E0436]$4.42tn [E0437]
Operating cash flow-$147.8bn [E0442]-$147.8bn [E0443]

ESG and red-flag checklist

Status per item with the threshold and source. Red or amber items are shown; items that could not be checked are marked unknown with the reason. [unconfirmed: G-26]

Count from the checklist: 0 red, 5 amber, 3 unknown (see Red-flag checklist). Top three: pre-planned insider selling with no purchases [E0178, GOV-6]; unverified news-only legal matters including a suit naming the CEO [LEG-3]; no deposit or credit-cost data in the evidence pack [E1078].

ItemStatusThresholdSource
Insider sellingAmberNet sales with zero purchases over 180 days; all pre-planned[E0178, GOV-6]
Legal: news-only suitsAmberMatters reported but not verified in dockets[LEG-1, LEG-2, LEG-3]
Political overhang (Senate probe)AmberTier-4 single headline, unconfirmed[E1141, G-26]
Cash flow vs net incomeAmberOperating cash flow -$147.8bn vs net income $57.0bn; bank-accounting artefact[E0442, E0463]
Piotroski scoreAmber3 of 7[E0894]
Altman ZUnknownNot meaningful for banks[E0891]
Credit costs and allowanceUnknownNo allowance or charge-off series in pack[E0004]
Capital ratios and buyback limitsUnknownNo CET1 or stress-test data in pack[E0006]
Credit spreadsGreenHY spread 3.2%, +0.04pp in 30 days[E0572, E0563]

What we could not find

Unknown stays unknown. These gaps were listed in the report itself.

  • No deposit cost, NII guidance or allowance for credit losses series in the evidence pack; this limits the test of the deposit-beta assumption [E0003]
  • No CET1 ratio, stress-capital-buffer or buyback data; this limits assessment of regulatory capital pressure [E0006]
  • No five-year standardised financial statements or debt maturity ladder; only FY2025 and TTM headline figures are available
  • No bank-specific peer set; the filing-based screen returned only non-bank names [E0641, E0644, E0652]
  • Earnings sensitivities to oil, rates and USD could not be estimated: zero usable quarters [E1078, E1082]
  • GDELT news tone was rate limited (HTTP 429) and social sources were skipped [E1250, E1211]
  • MiroFish had no precomputed run and the forecast module is disabled [E1024, E0419]
  • FINRA short-interest file is not available to the anonymous endpoint [E1125]
  • Proxy data on pay, board independence and related-party deals is absent, limiting the governance assessment
  • Prediction-market recession odds vary widely across contracts (28% to 76% for 2027) and rely on thin volume [E0844, E0838]
  • Industry and competitive position: No bank-specific peer set, industry size, growth or share data was returned; the filing-based screen produced only non-bank names. Carried to Gaps.
  • Financial analysis: The pack has no five-year statement history, CET1 ratio, debt maturity ladder or allowance data; only FY2025 and TTM headline figures were available. Carried to Gaps.
  • Estimates and what's priced in: A cash-flow reverse DCF is disabled for banks; no consensus EPS or NII estimate series is in the pack, so implied growth and margins vs history are not computed. Carried to Gaps.
  • Management and governance: The pack contains no proxy data on pay, board independence, related-party transactions or Dimon's succession; carried to Gaps.
  • Appendix: financial statements: The evidence pack holds headline FY2025 figures only, not full five-year standardised income statement, balance sheet and cash flow; carried to Gaps.
  • Key debates and what is priced in: Part of the underlying data is missing: A cash-flow reverse DCF is disabled for banks; no consensus EPS or NII estimate series is in the pack, so implied growth and margins vs history are not computed. Carried to Gaps.
  • Industry and competitive position: Part of the underlying data is missing: No bank-specific peer set, industry size, growth or share data was returned; the filing-based screen produced only non-bank names. Carried to Gaps.
  • Management, governance, government and insiders: Part of the underlying data is missing: The pack contains no proxy data on pay, board independence, related-party transactions or Dimon's succession; carried to Gaps.
  • Financial analysis and model summary: Part of the underlying data is missing: The pack has no five-year statement history, CET1 ratio, debt maturity ladder or allowance data; only FY2025 and TTM headline figures were available. Carried to Gaps.; The evidence pack holds headline FY2025 figures only, not full five-year standardised income statement, balance sheet and cash flow; carried to Gaps.

Disclosures

  • Pegasus Alpha is a research tool. This report is not investment advice and is not an offer or a solicitation to buy or sell any security.
  • Pegasus Alpha gives no rating and no price target. Where a range is shown it is a model range, not a target.
  • Every claim is cited to the evidence pack or marked as inference. Evidence tiers 1 to 5 apply; anything below tier 3 is unconfirmed.
  • Anything marked SIMULATED comes from a simulation. Simulations are never evidence.
  • Figures come from the public sources listed in the Sources section, as they were available on the date of the run. Gaps are listed in the Gaps section.